Education
About Us
Working with TipRanks
Follow Us
Haleon PLC Sponsored ADR (DE:H6D)
FRANKFURT:H6D
H6D Stock Chart & Stats
Day’s Range― - ―
52-Week Range€6.95 - €10.10
Previous CloseN/A
Volume102.00
Average Volume (3M)55.00
Market Cap
$42.76B
Enterprise Value€48.67B
Total Cash (Recent Filing)£1.04B
Total Debt (Recent Filing)£9.46B
Price to Earnings (P/E)24.8
Beta0.38
Next Earnings
Jul 31, 2025EPS Estimate
0.09Next Dividend Ex-Date
Apr 25, 2025Dividend Yield1.52%
Share Statistics
EPS (TTM)0.37
Shares Outstanding4,527,072,800
10 Day Avg. Volume45
30 Day Avg. Volume55
Financial Highlights & Ratios
PEG Ratio0.57
Price to Book (P/B)N/A
Price to Sales (P/S)3.24
Price to Cash Flow (P/CF)21.70
P/FCF Ratio21.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€9.96Price Target Upside4.82% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
---
Haleon PLC Sponsored ADR News
PremiumCompany Announcements
Haleon PLC Reports Strong 2024 Financial Performance---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
4.49% Mutual Funds
10.89% Other Institutional Investors
84.53% Public Companies and Individual Investors
H6D FAQ
What was Haleon PLC Sponsored ADR’s price range in the past 12 months?
Haleon PLC Sponsored ADR lowest stock price was €6.95 and its highest was €10.10 in the past 12 months.
What is Haleon PLC Sponsored ADR’s market cap?
Haleon PLC Sponsored ADR’s market cap is $42.76B.
When is Haleon PLC Sponsored ADR’s upcoming earnings report date?
Haleon PLC Sponsored ADR’s upcoming earnings report date is Jul 31, 2025 which is in 141 days.
How were Haleon PLC Sponsored ADR’s earnings last quarter?
Haleon PLC Sponsored ADR released its earnings results on Feb 27, 2025. The company reported €0.101 earnings per share for the quarter, beating the consensus estimate of €0.091 by €0.01.
Is Haleon PLC Sponsored ADR overvalued?
According to Wall Street analysts Haleon PLC Sponsored ADR’s price is currently Undervalued.
Does Haleon PLC Sponsored ADR pay dividends?
Haleon PLC Sponsored ADR pays a Semiannually dividend of €0.145 which represents an annual dividend yield of 1.52%. See more information on Haleon PLC Sponsored ADR dividends here
What is Haleon PLC Sponsored ADR’s EPS estimate?
Haleon PLC Sponsored ADR’s EPS estimate is 0.09.
How many shares outstanding does Haleon PLC Sponsored ADR have?
Haleon PLC Sponsored ADR has 4,527,072,800 shares outstanding.
What happened to Haleon PLC Sponsored ADR’s price movement after its last earnings report?
Haleon PLC Sponsored ADR reported an EPS of €0.101 in its last earnings report, beating expectations of €0.091. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Haleon PLC Sponsored ADR?
Currently, no hedge funds are holding shares in DE:H6D
---
Haleon PLC Sponsored ADR Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€9.96 (4.82% Upside)
€9.96 (4.82% Upside)
Blogger Sentiment
Bullish
DE:H6D Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.31%
12-Months-Change
Fundamentals
Return on Equity
8.90%
Trailing 12-Months
Asset Growth
-1.01%
Trailing 12-Months
Company Description
Haleon PLC Sponsored ADR
Haleon PLC is a consumer healthcare company and provides personal healthcare products. The group conducts business internationally across five consumer healthcare categories: Oral Health, Pain Relief, VMS, Respiratory Health and Digestive Health and Other. Its reportable and geographical segments includes North America; Europe, Middle East, Africa and Latin America (EMEA and LatAm) and Asia Pacific (APAC).
---
H6D Company Deck
---
H6D Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
Haleon demonstrated strong performance in emerging markets and innovation-driven growth, particularly in the Oral Health segment. However, challenges such as a weak cold and flu season, FX headwinds, and underperformance of the Eroxon launch present notable obstacles. The overall sentiment reflects a balanced view of both achievements and challenges.Read More>---
H6D Stock 12 Month Forecast
Average Price Target
€9.96
▲(4.82% Upside)
Technical Analysis
Colgate-Palmolive
―
Johnson & Johnson
―
Kimberly Clark
―
Procter & Gamble
―
Reynolds Consumer Products
―
Best Analysts Covering H6D
1 Year
1 Year Success Rate
3/4 ratings generated profit
1 Year Average Return
+12.93%
reiterated a buy rating 4 months ago
Copying Taylor Conrad's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +12.93% per trade.
---